Table 2.
Demographics, outcomes and clinical symptoms in patients infected with different SARS-CoV-2 variants.
| Demographics and outcomes (N = 417) | 20A (N = 336) | Marseille-1 (N = 81) | p-value* | |||
| n |
% |
n |
% |
|||
| Male gender | 149 | 44.4 | 46 | 56.8 | 0.044 | |
| Age (mean ± SD) | 50.2 ± 22.4 | 36.7 ± 17.5 | <0.0001 | |||
| Hospitalization | 53 | 15.8 | 3 | 3.5 | 0.004 | |
| Transfer to intensive care unit | 5 | 1.5 | 0 | 0 | 0.59 | |
| Death |
10 |
3.0 |
0 |
0 |
0.22 |
|
| Symptoms (N = 320) | 20A (N = 251) | Marseille-1 (N = 69) | p-valuea | |||
| n |
% |
n |
% |
|||
| Cough | 121 | 48.2 | 30 | 43.5 | 0.49 | |
| Rhinitis | 104 | 41.4 | 22 | 31.9 | 0.15 | |
| Anosmia | 76 | 30.3 | 25 | 36.2 | 0.35 | |
| Ageusia | 72 | 28.7 | 22 | 31.9 | 0.61 | |
| Dyspnea | 71 | 28.3 | 9 | 13.0 | 0.01 | |
| SpO 2 <96% | 49 | 19.5 | 2 | 2.9 | 0.001 | |
a
Chi2 or Fisher exact test for qualitative variables. Student's t-test for quantitative variables.